Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:11 PM
Ignite Modification Date:
2025-12-24 @ 7:11 PM
NCT ID:
NCT01579903
Eligibility Criteria:
Inclusion Criteria:
* Male patients at least 18 years old with severe or moderately severe hemophilia A (facto VIII concentration less than or equal to 2%).
* Negative test for facto VIII inhibitor.
* If applicable, HIV or hepatitis treatment is stable at the time of enrollment.
* Ability to abstain from use of FVIII products for 72 hours at a time.
Exclusion Criteria:
* History of any positive test result for factor VIII inhibitor.
* Presence of any bleeding disorder in addition to Hemophilia A.
* Body weight less than 50 kg.
* History of alcoholism.
* Treatment with investigational drug or device within 30 days prior to the Screening visit.
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
18 Years
Study:
NCT01579903
Study Brief:
Protocol Section:
NCT01579903